Life Flow One
The Solution For Heart Disease
by
Karl Loren
Proc 13 Int Congr Health, N.Y., 1960 (1961)
OUR EXPERIENCES WITH CaNa2EDTA
LJ. Petrovic, M.D.; M. Stankovic, Chem; M. Savicevic, M.D.; and D. Poleti, M.D:
Department of Industrial Medicine, Institute of Hygiene of the
People’s Republic of Serbia,
Avalska 13, Beograd, Yugoslavia
In 1947 Schwarzenbach and Ackerman discovered a new compound EDTA which belongs to the group of complexions. This drug was applied for the first time in the USA in 1952 in the therapy of lead poisoning, and the results obtained by other drugs used for that purpose. Late, this drug was applied in many countries and since then over 100 different papers, all favoring its positive effect, were made known. But the research work was limited to a small number of cases. Today CaNa2EDTA is the choice drug in treatment of lead poisoning.
In order to examine this drug completely, it was applied to persons who work with lead. The drug (Mosatil-Bayer) was applied to several groups and in different ways. The examination included a total of 92 persons.
Examination With Persons Chronically
Exposed to Lead Poisoning
* * * * *The fourth group (seven persons) was treated with Mosatil tablets, two tablets three times every day (0.5 g Ca2EDTA per tablet), during seven days.
* * * * * . Urinary lead excretion in persons that were treated parenterally, individually as well as a whole, was higher than in ones treated with tablets.
Figure 1 demonstrates urinary lead excretion. It is evident that this excretion is higher on the first day and that the differences for various groups are remarkable.
Subgroup B, also composed of eight workers, consumed 3g of Mosatil per day in three doses – at the beginning, in the middle, and at the end of working time. Tablets were also administered in a course of eight days. All the workers remained full time at their routine jobs.
The results obtained are shown in Figures 5 and 6.
Urinary lead excretion in Subgroup A reaches the maximum on the second day of administering tablets when it occurs, the average excretion values are about seven times higher than at the beginning. The following days this value decreases constantly, and two days after completion of administering it falls almost down to the pretreatment level. In Subgroup B urinary lead excretion is also maximal on the second day, and the quantities of excreted lead are eight times higher than at the beginning of treatment. It is evident the excretion in this subgroup remains longer and on a higher level than was the case in Subgroup A.
Urinary coproporphyrin excretion in Subgroup B during the whole period of time, especially after the third day of treatment, shows a more remarkable decrease in the Subgroup A.
During treatment blood lead diminished 0.015 mg per cent in Subgroup A and 0.030 mg per cent in Subgroup B.
The number of stippled cells diminished in both subgroups.
Thus it could be concluded that every worker of the Subgroup A excreted on an average 13.3 mg of lead per liter of urine. In other words, every worker in a course of eight days excreted as much lead he would do in33.9 days under normal circumstances without administering the tablets. Every worker of Subgroup B excreted on an average 17.8 mg of lead per liter of urine; that is, in the course of eight days every worker excreted as much lead he would normally do in 51.6 days if not treated with Mosatil.
* * * *
Conclusions
* * * *
4. On a trial of prophylactic values of Ca2EDTA tablets, administered from 1 to 3 g per day in a course of seven days, an increase of lead and decrease of coproporphyrin excretion in urine and decrease of blood lead as well as an improvement of clinical symptoms were found. Following intermission of administering Ca2EDTA, after a certain period of time after workers resumed their routine jobs, all these symptoms returned again to the levels established before treatment. Bearing in mind that this drug, like any other one, cannot be administered permanently in unlimited quantities, it does not represent a perfectly satisfactory medicine in the prophylactic of lead poisoning.
5. Regardless of the fact that resorption of Ca2EDTA is small by peroral administering, it is considered the drug can be applied, especially in cases where a possibility of consuming lead compounds does exist.
6. In the cases examined there were no side effects and/or toxic manifestations. Nevertheless, it is considered a thorough physical examination is necessary, especially for kidney damage; urine should be controlled during the whole period of administering CaNa2EDTA.
7. As a diagnostic test, CaNa2EDTA can be useful in those cases where diagnosis is not clear. If urinary lead excretion contains more that 0.34 mg per 24 hours after 3 g CaNa2EDTA tablets (32 tablets of 0.5 g three times per day) were administered, this is a symptom of rich lead depositions in the organism.
* * * *
10. Considering the individual safety appliances, as well as temporary administering of CaNa2EDTA, do not provide complete protection of the persons working with lead, it is essential – first of all on the working places where higher concentrations of lead are developed – that general hygienic and technical protection measures are maintained during the working process.
CaNa2EDTA TREATMENT IN MERCURY INTOXICAITON
L. Pilat, B. Moscovici, and M. Iorga
The clinic for Occupational Diseases of the University, Bucharest; and the Clinical Section of the Hygiene and Public Health Institute of Roumania, Colentina Hospital, Bucharest
There is a difference of opinion with regard to the efficiency of CaNa2EDTA for the treatment of mercury poisoning. N some cases the urinary mercury excretion remained stationary or even diminished while the symptoms were influenced (1,2); in other instances an increase up to nine times of the urinary mercury excretion was obtained, with improvement of the clinical picture in once case (3, 4).
On account of those discrepancies, we report the results obtained with CaNa2EDTA in five cases of subacute mercury poisoning, which allowed us to estimate the efficiency of this therapeutic method.
| The Links Below Jump To Pages On Whatever Web You Are In | |||
| Table Of Contents | Search This Web | Navigation Help Page | |
| Write To Karl Loren -- He Pledges To Answer EVERY Personal Message, Personally. Click here or on his name in the box below. | |||
| The Links Below Are To Various Web Sites Published By Karl Loren | |||
| Karl Loren Web | Vibrant Life Web | Karl Loren's Book | |
| Super Colostrum | Bulk MSM | Heart Disease | |
| Emmessar | Happiness | Arthritis | |
| Instead Of | Chelation Therapy | Super Colostrum (2) | |
| Karl Loren's Catalog Store | Central Page For All 12 Webs! | ||
|
I promise to answer your message -- click here to send me a personal message
|
|
SUBSCRIBE: The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren. You can view more than 50 back issues of this publication by clicking here. The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter. It is automatically published on the Tuesday night just before the first Wednesday of every month. You can subscribe to this free monthly electronic letter by entering your eMail address and name below. You will then automatically receive a request for confirmation, sent to whatever address you have entered. If you do NOT receive this confirmation request, then you will not be subscribed. There may have been an error with your address and you should resubmit. The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription. When you receive this confirmation request you must reply to it, or your subscription will not become active. No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.
REMOVAL: You can remove yourself from the subscription list in several different ways. Click here to read about this entire newsletter system. Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list. If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed. Thus, no one else can unsubscribe you, from some other computer, without your knowledge. But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.
Personal Message: When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions. Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US. You can select particular information you would like to receive, along with the free cassette tape and catalog.
Click here to add the Wednesday Letter as a Channel on your desktop. If your browser is so-equipped, you will be guided through a series of simple questions (about subscription information). Depending on your choices you can show the Vibrant Life Wednesday Letter as one of your "active channels" which will automatically download the new Wednesday Letter every month. In this way you can have the Wednesday Letter delivered to your desktop during the night (or your schedule) for immediate viewing in your browser. You can turn on or off this channel, at will, and delete the channel from your desktop at any time. With this feature operating you can click on the Wednesday Letter channel at any time to read the most recent copy of this electronic letter.
You can reach Vibrant Life in many ways, including by mail to Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504. Within the US and Canada, use the toll free number: (800) 523-4521, the local number: (818) 558-1799, the FAX: (818) 558-7299, eMail to kimberly@oralchelation.com or any one of the hundreds of message forms throughout the 50 web sites. Vibrant Life normally ships the same day we get an order. There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life. Check out our companion site, at: http://www.oralchelation.net where Karl's 2000 page book is published. Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION. His personal philosophical articles are at PHILOSOPHY.
Copyright © May 20, 2008 6:26 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED. Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions: One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site. This permission does not extend to materials on this site which are copyrighted by others.
